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blood components however remains a formidable
challenge faced by clinicians globally and in
particular, the developing nations. In Nigeria, the
advent of the National Blood Transfusion Service
(N.B.T.S) with zonal centres in the six geo-political
zones of the Country in the last three years offers
much hope of improvement in the situation.
Assessment of the impact of the N.B.T.S on the
overall use of blood components and blood
transfusion services in the country is however still in
its early stages. Two audit methods most widely used
in assessing the effectiveness of transfusion service
are a systems audit and a medical practice (clinical)
audit. Clinical audits are performed to assess the
appropriateness of transfusion practices while
systems audit assesses the operational aspects of
transfusion service. A one year clinical audit of the
use of blood and blood components at the Obafemi
Awolowo University Teaching Hospital Ile-Ife,
southwest Nigeria is presented.
Over a period of one year between January 2004 to
December 2004, blood and blood episodes carried
out in the hospital were prospectively evaluated. A
transfusion episode being the interval in patient care




Blood transfusion therapy has evolved remarkably
over the years since its introduction into clinical
practice. It has also become an indispensable life
saving measure in patient care. The use of blood and
blood components in clinical practice has
nonetheless continued to face challenges demanding
sustained efforts aimed at improvement in its use.
Prominent among such challenges is the issue of
transfusion transmitted diseases as well as the
unavailability of a reliable safe donor pool
particularly in developing nations. The goal of
modern transfusion therapy is to provide appropriate
replacement therapy with blood components (red
cells, platelets, fresh frozen plasma, cyoprecipitate
etc) as opposed to whole blood for patients with
specific haematologic deficiencies. Appropriate use
of components avoids some of the hazards
associated with the use of whole blood, and at the
same time makes maximal use of this valuable
resource. Whenever indicated, blood must be used in
such ways as to minimize patient exposure to
potential hazards, conserve a limited resource and to
contain costs. The appropriate use of safe blood and
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The appropriate use of blood and blood components remains a formidable challenge faced by
clinicians particularly in a developing country like Nigeria. The inadequate supply of safe blood implies that
measures aimed at ensuring judicious use of the available supply should be continually identified and explored.
Aprospective study to evaluate all blood and blood component transfusions over a period of one
year from January to December 2004 was done. The appropriateness of the transfusion with respect to the
clinical state and the transfusion needs of the recipient was assessed by a Haematologist.
A total of 682 transfusion episodes were reviewed and analyzed. The commonest indication for use
blood/blood component was severe anaemia in 38% of cases. Twenty nine percent of transfusions for moderate
anemia, and 36% of fresh frozen plasma transfusions were found to be unnecessary. Inappropriate transfusion
is most marked in the setting of platelet transfusion with 81% of platelet transfusion being inappropriate.
Enhanced capacity for component preparation, regular auditing of transfusion practices as well as
improved communication between the clinicians and laboratory physicians will lead to more judicious use of
blood component therapy. The need for the development of guidelines for blood component use in hospitals in
line with the national blood transfusion policy is highlighted.
Clinical audit; Blood components; inappropriate transfusion.
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Table 2: Summary of Transfusion Episodes for the Different Clinical Wards of Use.
RESULTS
Table Showing Distribution of Components
Transfused.
A total of 682 transfusion episodes were reviewed and
analysed. The distribution of the various blood
component types used for the duration of the study is
shown in table1, while the distribution of blood
component transfused per ward is shown in table 2. Red
cell transfusion constituted 67.7% of the total
component use. Of this, the Paediatrics wards accounted
for 33.3% while theAdult Medical,
Obstetrics and Gynaecology, and the Surgical Wards
accounted for 26.1%, 18.6% and 21.8% respectively.
Platelet preparations including the use of partial
platelets concentrate in lieu of platelet concentrates
accounted for 15.9% of the total component use. Use of
whole blood accounted for 5.7% of total transfusions
while fresh frozen plasma (FFP) transfusion accounted
for the remaining 10.5% of the transfusions carried out
during the study period. The indications for use of the
various blood/blood components are summarized in
table 3. Overall, the commonest indication for use of
blood/blood component was severe anaemia in 38.5% of
cases. Moderate anaemia with symptoms and surgery
accounted for 9.9% and 17.6% respectively.
Inappropriate transfusion is most marked in the setting
of platelet transfusions in this audit as 81% of such was
with partial platelet concentrate. Red cell transfusion is
the least inappropriately used blood component in this
study with an overall incidence of 3.4%.
Table 1:
* Used in lieu of platelet transfusion.
Component No %
Packed cells 462 67.8
*Partial platelet concentrates 88 12.9
Platelets 21 3.1
Whole blood 39 5.7
Fresh frozen plasma 72 10.5
Total 682 100%
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Defined number of units of whole blood or blood
components for a patient and the time of completion of
administration of these blood components to that
patient. Transfusion 'episodes' are characterized in
terms of only one blood unit or blood component type.
Component preparations in this study were done
through standard procedures. Fresh frozen plasma is
prepared by centrifuging freshly donated whole blood
(within 6 hours of collection) collected in double bag in
a cold centrifuge at a speed of 3000g for 20minutes and
the plasma supernatant separated in a pilot bag using
plasma expressor. Platelet concentrate preparation is
done by double a centrifuge of fresh whole blood; at
1000g for 6-9mins and then after the separation of the
supernatant into a satellite bag, at 3000g for 20mins.
The supernatant is discarded and the platelet
resuspended in 50-60mls of plasma.
However in the preparation of platelet concentrates,
non availability of multiple bags resulted in the use
“partial platelets concentrates; PPC” (Author
generated). Freshly collected whole blood is allowed to
settle under gravity or slightly centrifuged using a
bench centrifuge and a large fraction of the supernatant
plasma is then discarded to obtain the “partial platelets
concentrates”. The age, sex, ward of admission,
primary diagnosis, indication for transfusion as well as
the blood component transfused was summarized for
each patient. The measured outcome is the
appropriateness of the transfusion with respect to the
clinical state and need of the transfusion recipient as
assessed by a Haematologist in the absence of specific
hospital guidelines.
The clinical and laboratory data assessed include; Red
cells: Haemoglobin level and clinical parameters (pulse
rate and blood pressure); Platelets: Platelet count and
presence or absence of bleeding; Fresh frozen plasma
(FFP): Results of coagulation tests (prothrombin time
[PT] or international normalized ratio [INR] and
activated partial thromboplastin time [APTT]).
Coagulation time prolongation by more than 50% was
taken as reference . In view of the potentially
devastating effects of minor haemorrhage associated
with neurosurgical procedures, these were exempted























10(25.6%) 121(26.2%) 21(29.2%) 12(57.1%) 28(31.8%)
Adult
Surgical
14(35.8%) 101(21.9%) 19(26.4%) nil 16(18.2%)
Paediatrics 9 (23.1%) 154(33.3%) 24(33.3%) 9(42.9%) 32(36.4%)
Obst. & Gyn 6 (15.5%) 86(18.6%) 8(21.1%) nil 12(13.6%)
Table 3: Transfusion Episodes of Whole Blood, Red Cells, Platelets and Fresh Frozen Plasma.
Sixteen cases out of 64 transfusion episodes (29%)
were deemed inappropriate as such cases were not
symptomatic. Ten of the twenty eight peri-operative
transfusions using FFP (37%) were deemed
inappropriate as they did not meet the study criteria.
The use of whole blood for transfusion accounted for
5.7% of total transfusions in this study. A similar study
in 1996 reported that 60% of transfusion requests by
clinicians over a five year period at Ilorin, Kwara State
North central Nigeria were for whole blood. The
present study may be a preliminary indicator that there
may be a better awareness and appreciation of
component transfusion by clinicians over the period.
Unfortunately, the increased awareness of clinicians of
the need to use component transfusion as against whole
blood transfusion has not been met by a corresponding
enhanced capacity of our blood banks towards the
provision of blood components for clinical use. The
inauguration of the National blood transfusion service
(N.B.T.S) in 2005 expectedly brought a renewed hope
of improvement in the state of blood transfusion service
in Nigeria. However preliminary assessments show
that the N.B.T.S is still saddled with the immediate
problem of the recruitment of a reliable donor pool,
thus the provision of a regular supply of safe blood
components to hospitals across the length and breadth
of the Country as at when needed from the zonal
transfusion centers is yet to be realized. In
contemporary transfusion practice, there is little
justification for whole blood transfusion. An area of
current debate in the area of transfusion for trauma
patients relates to the management of trauma patients
with massive bleeding as a result of the risk of
DISCUSSION
6
Indication Total No Inappropriate Appropriate
Whole blood
Acute blood loss 21(53.8%) 0 100%
Surgery/Perioperative 14(46.2%) 100% 0
Red cells
Anaemia Hb<7g/dl 178(38%) 0 100%
Anaemia Hb7-10g/dl 62(13.4%) 16(29%) 71%
Surgery 106(22.9%) 0 100%
Haemodialysis 89(19.1%) 0 100%
Non-regenerative marrow 27(6.4%) 0 100%
Platelets and partial platelet concentrate
Therapeutic for bleeding 78(71%) 63(80.7%) 19.3%
Prophylaxis for thrombocytopenia 11(29%) 25(80.6%) 19.4%
Fresh Frozen Plasma
Prophylaxis in operative period 28(39%) 10(36%) 64%
Therapeutic for Bleeding
Correction of coagulopathy e.g
Liver disease, DIC. 39(54.1%) 0 100%
Correction of single factor
Deficiencies (suspected Haemophilics) 5(6.9%) ? ?
coagulopathy. In developed transfusion centers where
component therapy is the rule, it has been proposed that
coagulopathic trauma patients be primarily resuscitated
with FFP in a ratio of 1:1:1 to red blood cells and
platelets, virtually receiving “reconstituted whole
blood.” Thus transfusion of fresh whole blood is
justified in such circumstances.
However none of the whole blood transfusions given
peri-operatively in this audit could be justified and were
thus adjudged inappropriate.Red cell transfusion is the
least inappropriately used blood component in this
study, however the situation can still be improved upon.
Anaemia (reduction in haematocrit for the age and sex
in a patient) is described as mild if the packed cell value
isgreater than or equal to (>) 30% and physicians should
be discouraged from routinely transfusing patients with
mild anaemia. The “optimal” haemoglobin
concentration for pre and post operative patients
depends on the patient and the belief that a haemoglobin
value <10g/dl (haematocrit <30%) indicates a need for
red cell transfusion has been challenged. This is because
cardiac output does not change significantly until the Hb
decreases <7g/dl. Tissue oxygenation is generally
maintained at haematocrit levels as low as 30% as long
as the blood volume remains normal.
Between the limits of haematocrit levels 18%-30%,
(moderate anaemia), the decision to transfuse should be
based on a consideration of the patient's age,
cardiovascular and respiratory status, activity level,
symptoms, underlying diagnosis and the state of the
bone marrow activity. Many anaemic patients at or
above haematocrit of 25% (Hb 8g/dl) do not need
transfusion. However, the physiologic adjustments to
chronic anaemia have a limit and particularly in the
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compensated. The risks of bleeding in surgical and
obstetric patients are determined by the extent and type
of surgery, the ability to control bleeding, the actual and
anticipated rate of bleeding and the consequences of
uncontrolled bleeding. Severe anaemia (haematocrit
=18%, Hb =6g/dl) is usually an indication for blood
transfusion as the risk of cardiac decompensation is
high.
In about a third of cases (29%) of packed cell
transfusion for moderate anaemia in this study, the
transfusion was not necessary as such recipients were
well compensated and there was no dire need for it in
the clinical circumstance. This reflects a two fold value
of inappropriate use of red cells over the reported
incidence by Tuckfield et al in Australia prior to the
institution of prospective monitoring of transfusion
requests with the aim of reducing inappropriate use of
blood products. Platelet transfusion is usually
indicated in patients with increased risk of bleeding
from thrombocytopaenia. Prophylactic platelet
t ransfusion is however ineffect ive when
thrombocytopenia is due to increased platelet
Furthermore low manpower capacity for component
preparation is another major factor responsible for the
inappropriate use of blood components. Fresh-frozen
plasma is indicated for urgent reversal of warfarin
therapy, correction of known coagulation factor
deficiencies for which specific concentrates are
unavailable, and correction of microvascular bleeding
when prothrombin and partial thromboplastin times are
>1.5 times normal. Due to the potential case fatality
of microhaemorrhages for neurosurgical procedures
however, they are usually an exception to this rule.
The use of FFP by clinicians in this study was often left
to empirical reasoning, mainly as a result of inability of
the laboratory to carry out coagulation studies; PT
(with INR) and APTT due to lack of reagents to
perform these tests. In such circumstance, it is difficult







destruction. Surgical and obstetric patients with
microvascular bleeding usually require platelet
transfusion if the platelet count is less than 50 x109/l.11
Platelet component transfusion in this study is largely
inappropriate. This is mainly due to the non-
availability of multiple blood bags necessary for the
separation of the blood collected. The non availability
of multiple bags and equipment such as cell separators
is the most important single factor limiting component
preparation from the collected whole blood in this
centre.Amodified form of component transfusion used
in lieu of platelet concentrate transfusion is what is
referred to in this study as partial platelet concentrate.
This results in wastage of large volumes of plasma that
would otherwise have been prepared as fresh frozen
plasma but is discarded. This waste is even further
appreciated when considered in the context of the non
serviceable requests for FFP received during the same
period of study as a result of the “non-availability” of
FFP.
A limitation to this study is in the context of the
assessment of the appropriateness of FFPtransfusion for
single factor deficiency states. This is because factor
assays are not done routinely on suspected
Haemophiliac patients, making the judgment on volume
of plasma to be administered largely empirical. In all,
thirty six percent of FFP transfusion was deemed
inappropriate.
This value compares closely with the value of 30.2%
reported by Makroo et al for FFP requests in patients
who had normal coagulation parameters. Prospective
monitoring of transfusion requests by Haematologists
has been advocated as a measure to reduce the incidence
of inappropriate transfusion of blood components and
has been largely successful in reducing inappropriate
use of red cells and platelets in centers where this has
been introduced. Partial successes have also been
recorded for FFP use. This probably reflects uncertainty
about the appropriate clinical guidelines for FFP use.
The institution of a pre-transfusion approval program
requires that Haematologists agree on blood
components indications preferably through the
instrument of a consensus document on this subject. A
rational approach for improvement on blood component
use is the development of a framework, a working
document on blood component usage which is widely
accessible to clinicians. Blood is a scarce resource and
ensuring its clinical effectiveness requires investment-
both human and financial. The present study
corroborates the fact that appropriate use of blood and
blood components in most blood banks in Nigeria as in
many developing countries is a real and present
challenge.
The establishment of effective and functional
transfusion committees in each hospital in which
transfusion takes place and the establishment of a blood
transfusion policy to monitor and evaluate blood usage
is indispensable to the correct and appropriate use of
blood and blood components. The World Health
Organization recommends that each transfusion centre
develops a policy/document in accordance with the
National Blood Transfusion pol icy. The
policy/procedure document refers to a document that is
for hospital wide use and that is authorized in
accordance with hospital clinical policy/procedure
processes for such documents. The rational use of blood
and blood products is challenge for which the National
Blood Transfusion Service is well positioned as a central
coordinating unit for such committees in Nigerian
hospitals. The absence of a Hospital guideline for blood
transfusion in the centre of the present study is a major
constraint at ensuring the judicious use of blood and
blood components.
In addition to the provision of consumables and
equipment necessary for component preparation,
regular audits, ppropriate training of medical staff,
conducting regular CMEs to rationalize the use of blood
components would serve to improve on the current
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anaemia is poorly tolerated and the physician must
decide when the patient is approaching this limit.
Therefore in clinical situations of moderate anaemia,
such as anaemia of chronic illnesses, the decision for
transfusion should be taken in context of the patient,
and transfusion may not be necessary if the patient is
well therapy. A regular audit of blood request forms by
the Haematologists as is introduced in some centers
will further improve on optimization of blood
transfusion practices.
In conclusion, the study highlighted the inappropriate
use of blood component therapy in the centre of study.
The non-availability of cell separators, multiple blood
bags (double, triple bags and quadruple bags) for
component preparation, coupled with low manpower
capacity for component preparation in addition to a
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